Literature DB >> 16356438

Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia.

S Nadya J Kazzi1, Michael W Quasney.   

Abstract

OBJECTIVE: To explore whether the deletion (D) allele of angiotensin-converting enzyme (ACE) is associated with the risk or severity of bronchopulmonary dysplasia (BPD) among very low birth weight (BW) infants. STUDY
DESIGN: Infants with a BW < or = 1250 g were prospectively recruited. The D and I (insertion) alleles of ACE were determined using a polymerase chain reaction followed by restriction fragment length polymorphism analysis.
RESULTS: Infants with DD/DI genotype of ACE had a (mean +/- SD) birth weight (938 +/- 204 g vs 925 +/- 196 g) and gestational age (28 +/- 3 weeks vs 28 +/- 2 weeks), similar to infants with II genotype of ACE (P > .05). Infants with DD/DI genotype of ACE were more likely to have BPD than infants with II genotype (47% vs 22%, P = .025). Among infants with BPD, ACE DD/DI genotype was more common among infants with moderate or severe BPD compared with infants with mild BPD (74% vs 26%, P = .012). The number of D alleles of ACE correlated directly and positively with the severity of BPD (R = 0.23, P = .045).
CONCLUSION: The D allele of ACE is associated with an increased risk and severity of BPD among preterm infants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356438     DOI: 10.1016/j.jpeds.2005.07.029

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS.

Authors:  Pablo Cruces; Franco Díaz; Alonso Puga; Benjamín Erranz; Alejandro Donoso; Cristóbal Carvajal; Jan Wilhelm; Gabriela M Repetto
Journal:  Intensive Care Med       Date:  2011-10-18       Impact factor: 17.440

Review 2.  Impact of common genetic variation on neonatal disease and outcome.

Authors:  David Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-09       Impact factor: 5.747

Review 3.  Genetics of bronchopulmonary dysplasia in the age of genomics.

Authors:  Pascal M Lavoie; Marie-Pierre Dubé
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

4.  Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study.

Authors:  Joseph Fawke; Sooky Lum; Jane Kirkby; Enid Hennessy; Neil Marlow; Victoria Rowell; Sue Thomas; Janet Stocks
Journal:  Am J Respir Crit Care Med       Date:  2010-04-08       Impact factor: 21.405

5.  Genetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonates.

Authors:  K K Ryckman; J M Dagle; K Kelsey; A M Momany; J C Murray
Journal:  J Perinatol       Date:  2011-09-29       Impact factor: 2.521

6.  Angiotensin-converting enzyme D allele does not influence susceptibility to acute hypoxic respiratory failure in children.

Authors:  Adrian Plunkett; Rachel S Agbeko; Kawah Li; Steve E Humphries; Nigel J Klein; Mark J Peters
Journal:  Intensive Care Med       Date:  2008-09-12       Impact factor: 17.440

7.  Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health.

Authors:  Pascal M Lavoie; Chandra Pham; Kerry L Jang
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

8.  Genetic Contributions to the Development of Complications in Preterm Newborns.

Authors:  Chiara Poggi; Betti Giusti; Elena Gozzini; Alice Sereni; Ilaria Romagnuolo; Ada Kura; Elisabetta Pasquini; Rosanna Abbate; Carlo Dani
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

9.  Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure.

Authors:  Ali Reza Hosseini-Khalili; Julian Thompson; Anthony Kehoe; Nicholas S Hopkinson; A Khoshbaten; Mohammad Reza Soroush; Steve E Humphries; Hugh Montgomery; Mostafa Ghanei
Journal:  BMC Pulm Med       Date:  2008-08-14       Impact factor: 3.317

10.  ACE inhibition for severe bronchopulmonary dysplasia - an approach based on physiology.

Authors:  Arvind Sehgal; Mohan B Krishnamurthy; Megan Clark; Samuel Menahem
Journal:  Physiol Rep       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.